Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Mursla Bio Introduces AI Precision Medicine Platform Built on Organ-Specific EV Isolation from Blood

  • Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samples
  • Enables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, surrogate markers and other diagnostic development programs
  • Publication of pre-print data, with support from Evotec International GmbH and University College London demonstrates validation of Platform’s capability for liver diseases

Veranova Announces Strategic Investment to Establish cGMP Bioconjugation Capability in Devens, MA

Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, today announced a strategic investment to establish state-of-the-art bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus.

10 Tips for Scaling Your Lab Operations

When the goal is growth, building a scalable lab ops tech stack is critical. In a recent webinar, Joel Basken, Director of Operations, and Nicolette Surges, Lab Manager at Enveda Bioscience, a startup based in Colorado, shared invaluable insights and lessons on optimizing lab operations for scalability.

Enveda’s story: A real-life example of a scalable tech stack
The right tech stack for each startup varies, but Enveda has found success with the following solutions:

5th Reverse Pitch Webinar: Collaboration Opportunities with Japanese Pharmaceutical Companies

Department for Business and Trade (DBT) Japan are delighted to host the 5th webinar inviting speakers from the leading 5 Japanese pharmaceutical companies: Astellas Europe Ltd, Daiichi Sankyo Co Ltd, Eisai Co Ltd, Shionogi & Co Ltd and Takeda Pharmaceutical Company Limited to present their latest R&D collaboration wish list.

This webinar will provide an ideal opportunity for the UK companies / academia looking to learn the latest research priorities and collaboration structures of the leading Japanese pharmaceutical companies.

Gain a Unique Edge in Global Talent Recruitment: Corporate Housing Comes to Cambridge with Present Made, Eddington

As global companies compete fiercely for top-tier talent, those with a foothold in Cambridge now have an unprecedented advantage: corporate housing designed specifically to attract and retain the best. Present Made, Eddington, is leading the way with Cambridge’s first purpose-built, large-scale corporate letting scheme – a pioneering development that brings 21st-century executive living to one of the UK’s most dynamic science and technology hubs. 

Postdoc fellow– Bioinformatics & Executable Modelling for Rare Disease Digital Twins

We are looking for a motivated and talented postdoctoral-level researcher with experience in executable modelling to join a cutting-edge project developing Digital Twins for rare diseases. This is a unique opportunity to work at the intersection of systems biology, AI, and translational research, and to contribute to open science through the Chan Zuckerberg Initiative.

Your group
Petsalaki Group, in collaboration with Open Targets and BioModels teams.

How Can UK Tech & Life Sciences Companies Manage Tariffs Exposure

With the recent wave of US tariffs, UK businesses trading internationally face mounting cost pressures. For tech and life sciences companies, especially those sourcing physical goods from China and exporting to the US, these changes could significantly impact profitability and competitiveness.

Join us for an exclusive webinar hosted by Frazier & Deeter where our international tax and trade experts will explore how UK companies can manage tariff exposure

Speakers Include:

CN Bio Introduces Cross-species DILI Services to Enhance in Vitro to in Vivo Extrapolation During Preclinical Drug Development

  • Extends capabilities of industry-leading PhysioMimix DILI assay for comparative studies between animal species and human
  • Generates deeper insights into inter-species differences to de-risk development pipelines and minimize animal testing
Subscribe to